Physician

Joy Okwuwa, M.D

According to 2025 Medicare claims, Joy Okwuwa, M.D (NPI: 1194135574) practices nephrology in the Midland, TX market, with the plurality of this provider's patient population coming from Midland, TX. This provider's primary affiliated billing organization is MIDLAND KIDNEY CARE PLLC (NPI: 1881067973; TIN: 475493793) and primary practice location at 79703-5118. Okwuwa is affiliated with the CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Okwuwa's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 426 traditional Medicare patients, billed 1,653 HCPCS/CPT codes, and received $172,438 in Medicare payments. The top billing code was 90960 (Dialysis services, 4 or more physician visits per month (20 years or older)). Part D data shows 1,626 prescription claims across 353 beneficiaries totaling $568,852 in drug costs, led by Velphoro (Sucroferric Oxyhydroxide). DME data shows 61 claims. Open Payments data shows 7 records totaling $156. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $7,079 to $568,852. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	203	430	$47,198
2020	391	2,244	$278,188
2021	353	1,722	$230,278
2022	376	1,511	$213,437
2023	384	1,373	$192,308
2024	426	1,653	$172,438

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	32	188	$7,079
2016	34	136	$2,863
2017	43	172	$3,162
2018	33	109	$3,821
2019	51	121	$4,073
2020	205	805	$217,688
2021	244	1,103	$297,546
2022	269	1,258	$434,105
2023	299	1,318	$477,630
2024	353	1,626	$568,852

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	30	$1,079
2022	N/R	80	$2,293
2023	N/R	65	$1,592
2024	N/R	61	$1,448

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
90960	Dialysis services, 4 or more physician visits per month (20 years or older)	93	240	$266
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	110	131	$127
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	107	282	$89
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	144	200	$89
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	149	184	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Velphoro	Sucroferric Oxyhydroxide	95	3,240	$332,271
Auryxia	Ferric Citrate	36	1,320	$72,818
Jardiance	Empagliflozin	57	3,676	$71,415
Farxiga	Dapagliflozin Propanediol	17	930	$16,596
Sevelamer Carbonate	Sevelamer Carbonate	73	3,150	$10,479

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7507	Tacrolimus, immediate release, oral, 1 mg	N	N/R	19	$658
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	19	$358
J7517	Mycophenolate mofetil, oral, 250 mg	N	N/R	11	$282
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	12	$150

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	7	$156	Aurinia Pharma U.S., Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Joy Okwuwa, M.D?

Tedicare shows public-source Medicare data for Joy Okwuwa, M.D (NPI 1194135574), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Joy Okwuwa, M.D have ACO affiliation data?

Joy Okwuwa, M.D is shown with ACO affiliation data for CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Joy Okwuwa, M.D?

Joy Okwuwa, M.D is linked to MIDLAND KIDNEY CARE PLLC (billing NPI 1881067973) in the available physician profile data.

Does Joy Okwuwa, M.D have Open Payments data?

Joy Okwuwa, M.D has 7 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.